OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Traditional Chinese medicine reverses cancer multidrug resistance and its mechanism
Jiahui Wei, Zhilin Liu, Jie He, et al.
Clinical & Translational Oncology (2021) Vol. 24, Iss. 3, pp. 471-482
Closed Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

Artesunate-loaded solid lipid nanoparticles resist esophageal squamous cell carcinoma by inducing Ferroptosis through inhibiting the AKT/mTOR signaling
Xia Yu, Yixin Tang, Zhixin Huang, et al.
Cellular Signalling (2024) Vol. 117, pp. 111108-111108
Closed Access | Times Cited: 7

Study on the Chemical Composition and Multidrug Resistance Reversal Activity of Euphorbia uralensis (Euphorbiaceae)
Yina Ding, Yuhao Liu, Qiang Dang, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 1, pp. 412-412
Open Access

Traditional Chinese medicine in the era of immune checkpoint inhibitor: theory, development, and future directions
Yixuan Yu, Shuo Wang, Zhening Liu, et al.
Chinese Medicine (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 14

Nanoparticles for co-delivery of paclitaxel and curcumin to overcome chemoresistance against breast cancer
Xiangping Lin, Qun Wang, Shuang Du, et al.
Journal of Drug Delivery Science and Technology (2022) Vol. 79, pp. 104050-104050
Closed Access | Times Cited: 22

Cell plasticity modulation by flavonoids in resistant breast carcinoma targeting the nuclear factor kappa B signaling
Peter Kubatka, Lenka Koklesová, Alena Mazuráková, et al.
Cancer and Metastasis Reviews (2023) Vol. 43, Iss. 1, pp. 87-113
Open Access | Times Cited: 13

Targeting tumor-derived exosome-mediated premetastatic niche formation: The metastasis-preventive value of traditional Chinese medicine
Wentao Jia, Jiaying Yuan, Binbin Cheng, et al.
Cancer Letters (2023) Vol. 567, pp. 216261-216261
Closed Access | Times Cited: 11

Integrative Chinese-Western medicine strategy to overcome docetaxel resistance in prostate cancer
Lin Chen, Yuxin Xu, Yuan-Shuo Wang, et al.
Journal of Ethnopharmacology (2024) Vol. 331, pp. 118265-118265
Closed Access | Times Cited: 3

Targeting MCL1 with Sanggenon C overcomes MCL1-driven adaptive chemoresistance via dysregulation of autophagy and endoplasmic reticulum stress in cervical cancer
Wei Sun, Huarui Cai, Kui Zhang, et al.
Phytomedicine (2024) Vol. 133, pp. 155935-155935
Closed Access | Times Cited: 3

Tumor microenvironment diversity and plasticity in cancer multidrug resistance
Zhi Li, Peihao Yin
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 6, pp. 188997-188997
Closed Access | Times Cited: 9

Validation of Core Ingredients and Molecular Mechanism of Cinobufotalin Injection Against Liver Cancer
Shipeng Chen, Mengna Li, Changning Xue, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 1321-1338
Open Access | Times Cited: 2

Herba Patriniae and its component Isovitexin show anti-colorectal cancer effects by inducing apoptosis and cell-cycle arrest via p53 activation
Jinxiao Li, Luorui Shang, Fangyuan Zhou, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115690-115690
Open Access | Times Cited: 6

Modified Biejia Jianwan decoction restrains PD-L1-mediated immune evasion through the HIF-1α/STAT3/NF-κB signaling pathway
Xinchen Tian, Fen Liu, Zijian Wang, et al.
Journal of Ethnopharmacology (2023) Vol. 322, pp. 117577-117577
Open Access | Times Cited: 5

The metabolites from traditional Chinese medicine targeting ferroptosis for cancer therapy
Yu Tang, Ying Zhuang, Chuanxiang Zhao, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1

Lathyrol reduces the RCC invasion and incidence of EMT via affecting the expression of AR and SPHK2 in RCC mice
Shengyou Song, Lunwei Tai, Yuqi Xu, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1

Formononetin alleviates thermal injury-induced skin fibroblast apoptosis and promotes cell proliferation and migration
Meiyue Yang, Zhibo Yang, Xiangjun Huang, et al.
Burns (2024) Vol. 51, Iss. 1, pp. 107256-107256
Closed Access | Times Cited: 1

Chinese Medicine in Colorectal Cancer Treatment: From Potential Targets and Mechanisms to Clinical Application
Ke-Chen Guo, Zaozao Wang, Xiangqian Su
Chinese Journal of Integrative Medicine (2024)
Closed Access | Times Cited: 1

Exploration of Potential Targets and Mechanisms of Fisetin in the Treatment of Non-Small-Cell Lung Carcinoma via Network Pharmacology and In Vitro Validation
Junjun Ling, Yuhong Wang, Lihai Ma, et al.
Evidence-based Complementary and Alternative Medicine (2022) Vol. 2022, pp. 1-9
Open Access | Times Cited: 8

Systemic pharmacological verification of Salvia miltiorrhiza-Ginseng Chinese herb pair in inhibiting spontaneous breast cancer metastasis
Hongkuan Han, Cheng Qian, Gangfan Zong, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 156, pp. 113897-113897
Open Access | Times Cited: 8

Mechanisms involved in the HMGB1 modulation of tumor multidrug resistance (Review)
Lihua Shao, Li Zhu, Meng Wang, et al.
International Journal of Molecular Medicine (2023) Vol. 52, Iss. 2
Open Access | Times Cited: 3

Page 1 - Next Page

Scroll to top